Health Care & Life Sciences » Biotechnology | LegoChem Biosciences Inc.

LegoChem Biosciences Inc. | Cash Flow

Fiscal year is January-December. All values KRW Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
5,835,328.00
8,685,694.00
8,237,360.00
14,724,669.00
12,933,665.00
Depreciation, Depletion & Amortization
221,076.00
343,889.00
394,588.00
2,150,916.00
2,639,671.00
Other Funds
1,000,000.00
-
-
-
-
Funds from Operations
6,368,065.40
7,243,031.20
6,810,382.50
7,255,593.80
5,795,157.70
Changes in Working Capital
267,991.60
639,436.00
1,969,877.00
5,783,321.00
2,418,044.00
Net Operating Cash Flow
6,100,073.80
7,882,467.20
8,780,259.50
13,038,914.80
8,213,201.70
Capital Expenditures
1,234,378.70
290,496.40
365,006.20
4,242,341.70
2,540,882.70
Sale of Fixed Assets & Businesses
-
-
-
168,373.30
1,651,879.60
Purchase/Sale of Investments
-
-
9,535,727.40
-
-
Net Investing Cash Flow
16,065,457.40
10,921,771.40
9,408,048.90
20,153,249.50
13,539,955.90
Issuance/Reduction of Debt, Net
45,000.00
11,400,000.00
-
8,700,000.00
-
Net Financing Cash Flow
21,741,223.50
19,084,206.40
189,492.80
33,716,671.00
329,271.20
Net Change in Cash
424,338.50
279,539.50
821,006.50
525,141.90
5,654,523.30
Free Cash Flow
7,314,250.00
8,172,963.60
9,145,265.70
17,281,256.50
10,411,861.30
Other Sources
11,840,913.30
24,381,482.40
237,327.80
19,973,163.00
63,617,502.70
Change in Capital Stock
20,786,223.50
7,684,206.40
189,492.80
25,016,671.00
329,271.20
Exchange Rate Effect
30.80
428.40
3,724.40
635.30
1,502.10
Other Uses
26,671,992.00
35,012,757.30
-
36,052,444.20
49,188,543.60

About LegoChem Biosciences

View Profile
Address
8-26 Munpyeongseo-ro
Daejeon DE 34302
Korea, Republic Of
Employees -
Website http://www.legochembio.com
Updated 09/14/2018
LegoChem Biosciences, Inc. engages in the development and manufacturing of pharmaceuticals. Its main therapeutic areas include antibiotics, anti-coagulants, oncology, antibody-drug conjugate and protein-drug conjugate. The company was founded on May 2, 2006 and is headquartered in Daejeon, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.